Anti-Mouse Fas Ligand (Clone 101624)

Leinco Technologies
Product Code: LEI-F1074
Product Group: Primary Antibodies
CodeSizePrice
LEI-F1074-25ug25 ug£375.00
Quantity:
LEI-F1074-500ug500 ug£773.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rat
Antibody Isotype: IgG1
Antibody Clonality: Monoclonal
Antibody Clone: 101624
Regulatory Status: RUO
Target Species: Mouse
Applications:
  • Neutralisation
  • Western Blot (WB)
Shipping:
Ambient
Storage:
The lyophilized antibody can be stored desiccated at -20°C to -70°C for up to twelve months. The reconstituted antibody can be stored for at least four weeks at 2-8°C. For long-term storage of the reconstituted antibody aseptically aliquot into working volumes and store at -20°C to -70°C in a manual defrost freezer. Avoid repeated freeze thaw cycles. No detectable loss of activity was observed after six months.

Further Information

Conjugate/Tag/Label:
Purified No Carrier Protein
Format:
This monoclonal antibody has been 0.2 um filtered and lyophilized from modified Dulbecco's phosphate buffered saline (1X PBS) pH 7.2 - 7.3 containing 5.0% w/v trehalose with no calcium, magnesium or preservatives present.
Formulation:
This monoclonal antibody has been 0.2 um filtered and lyophilized from modified Dulbecco's phosphate buffered saline (1X PBS) pH 7.2 - 7.3 containing 5.0% w/v trehalose with no calcium, magnesium or preservatives present.
Immunogen:
NS0-Derived Recombinant Mouse Fas Ligand
Long Description:
Fas ligand (FasL) is a type II transmembrane protein that belongs to the tumor necrosis factor (TNF) family. Fas ligand is a homotrimeric protein and signals through trimerization of FasR, which spans the membrane of the "target" cell. This trimerization usually leads to apoptosis, or cell death. Soluble Fas ligand is generated by cleaving membrane-bound FasL at a conserved cleavage site by the external serine matrix metalloproteinase MMP-7. Soluble FasL is less active than their membrane-bound counterparts and do not induce receptor trimerization and DISC formation. FasL is regarded as a potential target for immunotherapy.1
Target:
Fas Ligand

References

1. Igney, FH. et al. (2005) Cancer Immunol. Immunother. 54:11272. Ottmar, J. et al. (2008) Cell Communication and Signaling 6:113. Stuart, P. et al. (1997) J. Clin. Investigation 99:396

Related Products

Product NameProduct CodeSupplier 
Recombinant Mouse Fas LigandLEI-F1037Leinco Technologies Summary Details
Anti-Mouse Fas Ligand (Clone 101626)LEI-F1075Leinco Technologies Summary Details
Anti-Mouse Fas LigandLEI-F1088Leinco Technologies Summary Details
Anti-Mouse Fas Ligand - BiotinLEI-F1099Leinco Technologies Summary Details
Anti-Human Fas LigandLEI-F1126Leinco Technologies Summary Details